These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6853905)

  • 1. Electrophysiologic and antiarrhythmic effects of oral flecainide in patients with inducible ventricular tachycardia.
    Anderson JL; Lutz JR; Allison SB
    J Am Coll Cardiol; 1983 Jul; 2(1):105-14. PubMed ID: 6853905
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the antiarrhythmic effects on AV junctional re-entrant tachycardia of oral and intravenous flecainide acetate.
    Bexton RS; Hellestrand KJ; Nathan AW; Spurrell RA; Camm AJ
    Eur Heart J; 1983 Feb; 4(2):92-102. PubMed ID: 6852073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrograde gap in fast pathway conduction accentuated by the class I antiarrhythmic agent, flecainide.
    Bexton RS; Hellestrand KJ; Nathan AW; Banim SO; Camm AJ
    Pacing Clin Electrophysiol; 1983 Nov; 6(6):1273-7. PubMed ID: 6196737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and electrophysiologic assessment of oral flecainide acetate for recurrent ventricular tachycardia: evidence for exacerbation of electrical instability.
    Oetgen WJ; Tibbits PA; Abt ME; Goldstein RE
    Am J Cardiol; 1983 Oct; 52(7):746-50. PubMed ID: 6624666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adenosine on retrograde refractoriness of accessory atrioventricular connections.
    Kabell G; Corbisiero R; Miller GD; Fitzgerald TF; Cook JR; Kirchhoffer JB
    Am J Cardiol; 1998 Sep; 82(5):680-3, A8. PubMed ID: 9732903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electrophysiological effects of flecainide on stimulus-inducible ventricular tachycardia].
    Breithardt G; Borggrefe M; Yeh HL; Seipel L
    Z Kardiol; 1982 Apr; 71(4):278-83. PubMed ID: 7090468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intravenous and oral flecainide on ventricular tachycardia.
    Ward DE; Cheesman M; Dancy M
    Int J Cardiol; 1986 Mar; 10(3):251-62. PubMed ID: 3957470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical electrophysiology of intravenous indecainide.
    Horowitz LN; Spielman SR; Webb CR; Morganroth J; Greenspan AM
    Am Heart J; 1985 Oct; 110(4):784-8. PubMed ID: 4050649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
    Kim SS; Lal R; Ruffy R
    Am J Cardiol; 1986 Jul; 58(1):80-5. PubMed ID: 3728336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
    Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic effects of flecainide acetate and its major metabolites in the canine heart.
    Guehler J; Gornick CC; Tobler HG; Almquist A; Schmid JR; Benson DW; Benditt DG
    Am J Cardiol; 1985 Mar; 55(6):807-12. PubMed ID: 3919554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleomorphic ventricular tachycardia with antegrade His-bundle activation: elucidation by multiple His-bundle recordings.
    Tai YT; Lee KL
    J Cardiovasc Electrophysiol; 1994 Apr; 5(4):350-5. PubMed ID: 8019710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic effects of flecainide acetate on sinus node function, anomalous atrioventricular connections, and pacemaker thresholds.
    Hellestrand KJ; Nathan AW; Bexton RS; Camm AJ
    Am J Cardiol; 1984 Feb; 53(5):30B-38B. PubMed ID: 6695817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flecainide: steady state electrophysiologic effects in patients with remote myocardial infarction and inducible sustained ventricular arrhythmia.
    Webb CR; Morganroth J; Senior S; Spielman SR; Greenspan AM; Horowitz LN
    J Am Coll Cardiol; 1986 Jul; 8(1):214-20. PubMed ID: 3711519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia.
    Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN
    Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate.
    Nathan AW; Hellestrand KJ; Bexton RS; Banim SO; Spurrell RA; Camm AJ
    Am Heart J; 1984 Feb; 107(2):222-8. PubMed ID: 6695656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial tachycardia secondary to sino-atrial node reentry.
    Paritzky Z; Obayashi K; Mandel WJ
    Chest; 1974 Nov; 66(5):526-9. PubMed ID: 4430204
    [No Abstract]   [Full Text] [Related]  

  • 18. His-Purkinje system reentry as a proarrhythmic effect of flecainide.
    Chalvidan T; Cellarier G; Deharo JC; Colin R; Savon N; Barra N; Peyre JP; Djiane P
    Pacing Clin Electrophysiol; 2000 Apr; 23(4 Pt 1):530-3. PubMed ID: 10793448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical electrophysiology of ventricular tachycardia.
    Kastor JA; Horowitz LN; Harken AH; Josephson ME
    N Engl J Med; 1981 Apr; 304(17):1004-19. PubMed ID: 7010169
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lorcainid--electrophysiologic examinations of a new anti-arrhythmia agent].
    Gstöttner M; Ng CK; Gmeiner R
    Acta Med Austriaca; 1978; 5(4-5):137-8. PubMed ID: 756123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.